Abstract
Allergic conjunctivitis is the most common ocular allergic disease. Although very symptomatic it does not endanger vision, and topical antihistamines or chromones are the first choice treatment in clinical practice. Recently, equivalent nanomolar affinities for histamine H 1 and muscarinic M 1 and M 3 cloned human receptors have been reported for desloratadine, the active metabolite of loratadine, a widely prescribed antihistamine. This property might enhance its utility in the treatment of asthma, but could induce adverse anticholinergic effects after topical administration. In the present study, we compare the anticholinergic activity of desloratadine with other known muscarinic antagonists and antihistamines on rabbit and guinea-pig iris smooth muscle. Desloratadine was found to be a competitive antagonist (p A 2=6.67±0.09) of carbachol-induced contractions in isolated rabbit iris smooth muscle. Atropine (p A 2=9.44±0.02) and NPC-14695 (p A 2=9.18±0.03) also behaved as competitive antagonists, whereas tiotropium bromide (p D 2′=9.06±0.02) exhibited a non-competitive behaviour in this tissue. Carebastine (p A 2=5.64±0.04) and fexofenadine (p A 2<4.0) were also studied. After topical administration on the guinea-pig eye conjunctiva, desloratadine produced a potent (ED 50=2.3 mg/ml) and long lasting mydriasis (>120 min at the ED 50) in conscious animals. Fexofenadine and carebastine were inactive even at the highest concentration tested (10 mg/ml). Atropine (ED 50=30 μg/ml) and tiotropium bromide (ED 50=10 μg/ml) were much more potent than desloratadine or pirenzepine (ED 50=3 mg/ml) in this model. The competitive muscarinic antagonism of desloratadine in vitro, and its potency and duration of action in vivo, suggest that topical treatment of allergic conjunctivitis and rhinitis with desloratadine could produce undesirable peripheral anticholinergic side effects such as mydriasis and xerostomia.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
